1
Chen, P. Y., Su, I. C., Shih, C. Y., Liu, Y. C., Su, Y. K., Wei, L., Luh, H. T., Huang, H. C., Tsai, P. S., Fan, Y. C., & Chiu, H. Y. (2023). Effects of Neurofeedback on Cognitive Function, Productive Activity, and Quality of Life in Patients With Traumatic Brain Injury: A Randomized Controlled Trial. Neurorehabilitation and neural repair, 37(5), 277–287. https://doi.org/10.1177/15459683231170539
2
Huang, W. K., Hsu, H. C., Yang, T. S., Lu, C. W., Pan, Y. R., Wu, C. E., Chung, W. H., Hung, S. I., & Yeh, C. N. (2023). Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial. European journal of cancer (Oxford, England : 1990), 195, 113286. https://doi.org/10.1016/j.ejca.2023.113286
3
Shen, W. C., Hou, M. M., Huang, T. L., Wang, C. H., Huang, Y. M., Chen, J. S., & Chen, M. L. (2023). Transdermal buprenorphine improves overall quality of life and symptom severity in cancer patients with pain. Journal of clinical nursing, 32(3-4), 539–547. https://doi.org/10.1111/jocn.16303
4
Huang, T. L., Huang, Y. M., Hou, M. M., Lu, C. H., Chao, T. Y., Chiu, T. J., Chang, Y. S., Lin, S. H., Lin, C. H., Chen, Y. H., Wang, C. H., Chen, J. S., & Shen, W. C. (2023). Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE). Asia-Pacific journal of clinical oncology, 19(2), e45–e53. https://doi.org/10.1111/ajco.13772
5
Wang, C. H., Chen, W. S., Liu, M. H., Lee, C. Y., Wang, M. Y., Liang, C. Y., Chu, C. M., Wu, H. P., & Chen, W. H. (2022). Stress Hyperphenylalaninemia Is Associated With Mortality in Cardiac ICU: Clinical Factors, Genetic Variants, and Pteridines. Critical care medicine, 50(11), 1577–1587. https://doi.org/10.1097/CCM.0000000000005640
6
Wei, Y. C., Chen, C. K., Lin, C., Chen, P. Y., Hsu, P. C., Lin, C. P., Shyu, Y. C., & Huang, W. Y. (2022). Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan. Dementia and geriatric cognitive disorders, 51(4), 365–376. https://doi.org/10.1159/000525615
7
Yang, J. Y., Chen, C. C., Chang, S. C., Yeh, J. T., Huang, H. F., Lin, H. C., Lin, S. H., Lin, Y. H., Wei, L. G., Liu, T. J., Hung, S. Y., Yang, H. M., Chang, H. H., Wang, C. H., Tzeng, Y. S., Huang, C. H., Chou, C. Y., Lin, Y. S., Yang, S. Y., Chen, H. M., … Dai, N. T. (2022). ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trial. EClinicalMedicine, 51, 101497. https://doi.org/10.1016/j.eclinm.2022.101497
8
Chen, J. Y., Hsieh, S. M., Hwang, S. J., Liu, C. S., Li, X., Fournier, M., Yeh, T. Y., Yin, J. K., & Samson, S. I. (2022). Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study. Vaccine, 40(45), 6450–6454. https://doi.org/10.1016/j.vaccine.2022.09.078
9
Lee, C. T., Lee, C. C., Wu, M. J., Chiu, Y. W., Leu, J. G., Wu, M. S., Peng, Y. S., Wu, M. S., & Tarng, D. C. (2022). Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial. PloS one, 17(3), e0264727. https://doi.org/10.1371/journal.pone.0264727
10
Hsieh, M. J., Chen, N. H., Cheng, S. L., Tao, C. W., Wei, Y. F., Wu, Y. K., Chan, M. C., Liu, S. F., Hsu, W. H., Yang, T. M., Lin, M. S., Liu, C. L., Kuo, P. H., & Tsai, Y. H. (2022). Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study. International journal of chronic obstructive pulmonary disease, 17, 967–976. https://doi.org/10.2147/COPD.S353799